ATROPINE SULFATE — AMNEAL, approved 2022-01-26 (ANDA215342).
22,767 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.